Drug-resistant strains of golden staph can be rapidly identified in less than 40 minutes using this new combination of technology. This allows providers to rapidly address infections with appropriate treatments to reduce the 700,000 deaths that occur annually related to drug-resistant infections.
Posted by Rebecca Harris
Rebecca Moody Harris is a CPA and CFO with over eighteen years of progressive financial experience. For the last twelve years, she has served the healthcare industry in CFO and executive leadership roles. Her experience ranges from large corporations to start-ups in the private sector, and Rebecca specializes in Mergers and Acquisitions, Private Equity fundraising, and computer information systems.
